探索轴性脊柱关节炎治疗的最新进展

IF 29.4 1区医学 Q1 RHEUMATOLOGY

Nature Reviews Rheumatology Pub Date : 2024-01-08 DOI:10.1038/s41584-023-01072-7

Diego Benavent, Victoria Navarro-Compán

引用次数: 0

摘要

2023 年发表的研究强调了新型疗法对放射性和非放射性轴性脊柱关节炎（axSpA）的长期疗效和安全性，并提供了 "早期 axSpA "的共识定义，供研究使用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Exploring the latest advances in axial spondyloarthritis management

Studies published in 2023 emphasize the long-term efficacy and safety of novel therapeutics for both radiographic and non-radiographic axial spondyloarthritis (axSpA) and provide a consensus definition of ‘early axSpA’ for use in research studies.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Nature Reviews Rheumatology 医学-风湿病学

CiteScore

29.90

自引率

0.90%

发文量

137

审稿时长

6-12 weeks

期刊介绍： Nature Reviews Rheumatology is part of the Nature Reviews portfolio of journals. The journal scope covers the entire spectrum of rheumatology research. We ensure that our articles are accessible to the widest possible audience.